Temozolomide (TMZ) with O6-benzylguanine (BG) for TMZ-resistant malignant glioma: A phase 2 trial

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Quinn, J; Reardon, D; Rich, J; Sathornsumetee, S; Vredenburgh, J; Walker, A; Tourt-Uhlig, S; Bigner, D; Friedman, H

Published Date

  • July 1, 2005

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 401 - 401

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology

Conference Location

  • Edinburgh, SCOTLAND

Conference Start Date

  • May 5, 2005

Conference End Date

  • May 8, 2005